Atlas Trials

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

Clinical trial NCT03516812 · COMPLETED

Trial details

NCT number
NCT03516812
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma
Start date
2018-08-29
Primary completion
2021-03-05
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.